✦ LIBER ✦
Double-blinded, Placebo-controlled Randomized Study Evaluating the Efficacy of Risedronate to Prevent the Loss of Bone Mineral Density in Non-metastatic Prostate Cancer Patients Undergoing Radiotherapy Plus 2-3 Years of Androgen Ablation Therapy
✍ Scribed by C. Choo; H. Lukka; A. Kiss; C. Danjoux
- Book ID
- 118455845
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 44 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.